511509 VIVOBIOT

Vivo Bio Tech Share Price

₹38.93 +2.7 (7.45%)

23 Dec, 2024 08:19

SIP TrendupStart SIP in VIVOBIOT

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume0

Investment Returns

  • Over 1 Month + 0.93%
  • Over 3 Month -0.69%
  • Over 6 Month -3.06%
  • Over 1 Year + 17.15%
SIP Lightning

Smart Investing Starts Here Start SIP with Vivo Bio Tech for Steady Growth!

Invest Now

Vivo Bio Tech Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Vivo Bio Tech Financials

Vivo Bio Tech Technicals

EMA & SMA

Current Price
₹38.93
+ 2.7 (7.45%)
pointer
  • stock-down_img
  • Bullish Moving Average 15
  • stock-up_img
  • Bearish Moving Average 1
  • 20 Day
  • ₹37.55
  • 50 Day
  • ₹37.69
  • 100 Day
  • ₹38.10
  • 200 Day
  • ₹38.31

Resistance and Support

39.78 Pivot Speed
  • R3 49.16
  • R2 46.32
  • R1 42.62
  • S1 36.08
  • S2 33.24
  • S3 29.54

What's your outlook on Vivo Bio Tech?

You can only vote for once

Vivo Bio Tech Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-21 Employees Stock Option Plan
2024-11-14 Quarterly Results
2024-08-10 Quarterly Results
2024-05-20 Audited Results
2024-02-12 Quarterly Results

Vivo Bio Tech F&O

Vivo Bio Tech Shareholding Pattern

No data available.

About Vivo Bio Tech

  • NSE Symbol
  • VIVOBIOT
  • BSE Symbol
  • 511509
  • ISIN
  • INE380K01017

Similar Stocks to Vivo Bio Tech

Vivo Bio Tech FAQs

Vivo Bio Tech share price is ₹38 As on 23 December, 2024 | 08:05

The Market Cap of Vivo Bio Tech is ₹58 Cr As on 23 December, 2024 | 08:05

The P/E ratio of Vivo Bio Tech is 7.8 As on 23 December, 2024 | 08:05

The PB ratio of Vivo Bio Tech is 1.1 As on 23 December, 2024 | 08:05

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23